Generali Investments CEE investicni spolecnost a.s. Takes Position in Healthcare Realty Trust Incorporated (NYSE:HR)

Generali Investments CEE investicni spolecnost a.s. bought a new position in shares of Healthcare Realty Trust Incorporated (NYSE:HR - Free Report) in the 4th quarter, according to the company in its most recent Form 13F filing with the Securities and Exchange Commission (SEC). The firm bought 81,900 shares of the real estate investment trust's stock, valued at approximately $1,388,000.

Other institutional investors and hedge funds also recently added to or reduced their stakes in the company. Smartleaf Asset Management LLC raised its stake in shares of Healthcare Realty Trust by 59.0% during the 4th quarter. Smartleaf Asset Management LLC now owns 1,650 shares of the real estate investment trust's stock valued at $27,000 after buying an additional 612 shares during the last quarter. Pacer Advisors Inc. raised its position in Healthcare Realty Trust by 1.1% during the fourth quarter. Pacer Advisors Inc. now owns 70,776 shares of the real estate investment trust's stock valued at $1,200,000 after acquiring an additional 786 shares in the last quarter. Park Avenue Securities LLC lifted its holdings in Healthcare Realty Trust by 4.1% in the fourth quarter. Park Avenue Securities LLC now owns 20,193 shares of the real estate investment trust's stock valued at $342,000 after acquiring an additional 793 shares during the period. Consolidated Portfolio Review Corp boosted its position in Healthcare Realty Trust by 1.5% in the 4th quarter. Consolidated Portfolio Review Corp now owns 55,333 shares of the real estate investment trust's stock worth $938,000 after purchasing an additional 808 shares in the last quarter. Finally, Blue Trust Inc. grew its stake in shares of Healthcare Realty Trust by 130.3% during the 4th quarter. Blue Trust Inc. now owns 1,635 shares of the real estate investment trust's stock worth $30,000 after purchasing an additional 925 shares during the period.

Insider Activity

In related news, Director Peter F. Sr Lyle, Sr. purchased 10,000 shares of the company's stock in a transaction dated Friday, December 13th. The stock was acquired at an average cost of $17.21 per share, for a total transaction of $172,100.00. Following the completion of the transaction, the director now directly owns 26,576 shares of the company's stock, valued at approximately $457,372.96. This trade represents a 60.33 % increase in their ownership of the stock. The transaction was disclosed in a legal filing with the Securities & Exchange Commission, which is available through this link. Company insiders own 0.56% of the company's stock.

Analysts Set New Price Targets

A number of brokerages recently issued reports on HR. Scotiabank lowered their price target on shares of Healthcare Realty Trust from $18.00 to $17.00 and set a "sector perform" rating on the stock in a report on Tuesday, February 25th. Jefferies Financial Group lowered shares of Healthcare Realty Trust from a "buy" rating to a "hold" rating and lowered their target price for the stock from $19.00 to $17.00 in a research note on Thursday, January 2nd. Wedbush restated an "outperform" rating and issued a $16.00 price target on shares of Healthcare Realty Trust in a research note on Thursday, February 20th. JPMorgan Chase & Co. downgraded Healthcare Realty Trust from an "overweight" rating to a "neutral" rating and set a $19.00 price target on the stock. in a research report on Friday, December 20th. Finally, StockNews.com cut Healthcare Realty Trust from a "hold" rating to a "sell" rating in a research report on Wednesday. Two equities research analysts have rated the stock with a sell rating, three have assigned a hold rating and one has assigned a buy rating to the company's stock. According to data from MarketBeat.com, the company currently has a consensus rating of "Hold" and a consensus target price of $17.20.

Remove Ads

Healthcare Realty Trust Trading Up 1.6 %

Shares of Healthcare Realty Trust stock opened at $16.78 on Friday. Healthcare Realty Trust Incorporated has a twelve month low of $12.77 and a twelve month high of $18.90. The firm has a market capitalization of $5.89 billion, a PE ratio of -9.42 and a beta of 0.97. The firm's 50-day moving average price is $16.61 and its 200 day moving average price is $17.34.

Healthcare Realty Trust (NYSE:HR - Get Free Report) last released its earnings results on Wednesday, February 19th. The real estate investment trust reported $0.40 earnings per share for the quarter, beating the consensus estimate of $0.39 by $0.01. Healthcare Realty Trust had a negative return on equity of 11.20% and a negative net margin of 51.60%. The business had revenue of $309.77 million for the quarter, compared to the consensus estimate of $303.81 million. During the same quarter last year, the business posted $0.39 earnings per share. The business's quarterly revenue was down 6.3% compared to the same quarter last year. On average, sell-side analysts predict that Healthcare Realty Trust Incorporated will post 1.59 EPS for the current fiscal year.

Healthcare Realty Trust Dividend Announcement

The firm also recently announced a quarterly dividend, which will be paid on Wednesday, March 19th. Stockholders of record on Monday, March 3rd will be issued a dividend of $0.31 per share. This represents a $1.24 dividend on an annualized basis and a dividend yield of 7.39%. The ex-dividend date is Monday, March 3rd. Healthcare Realty Trust's payout ratio is -69.66%.

Healthcare Realty Trust Profile

Healthcare Realty Trust, Inc provides real estate investment services. It owns, leases, manages, acquires, finances, develops, and redevelops income-producing real estate properties associated primarily with the delivery of outpatient healthcare services throughout the United States of America. The company was founded by David R.

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest and most accurate reporting. This story was reviewed by MarketBeat's editorial team prior to publication. Please send any questions or comments about this story to contact@marketbeat.com.